NCT06070389 is a NA clinical trial of Sansa device in Sleep-Disordered Breathing, sponsored by Huxley Medical, Inc..

Who is sponsoring NCT06070389?

NCT06070389 is sponsored by Huxley Medical, Inc..

What drugs are being tested in NCT06070389?

Interventions in NCT06070389: Sansa device.

What condition does NCT06070389 study?

NCT06070389 studies Sleep-Disordered Breathing.

Is NCT06070389 still recruiting?

NCT06070389 is currently completed. Last updated 14 August 2024.

Last reviewed 2024-08-14 · How we verify

NCT06070389

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polysomnography Validation of the Sansa Device

Completed NA Last updated 14 August 2024

What this trial tests

NA trial testing Sansa device in Sleep-Disordered Breathing in 533 participants. Completed in 13 December 2023.

Timeline

1 June 2023

Primary endpoint
13 December 2023

13 December 2023

Quick facts

Lead sponsor	Huxley Medical, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	533
Start date	1 June 2023
Primary completion	13 December 2023
Estimated completion	13 December 2023
Sites	2 locations across United States

Drugs / interventions tested

Sansa device

Conditions studied

Sleep-Disordered Breathing — all drugs for Sleep-Disordered Breathing →

Sponsor

Huxley Medical, Inc.

Who can join

18 and older, any sex, with Sleep-Disordered Breathing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the performance of the Sansa device for the diagnosis of sleep disordered breathing.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Polysomnography validation of SANSA to detect obstructive sleep apnea.
Goldstein C, Ghanbari H, Sharma S, Collop N, et al · · 2025 · cited 1× · PMID 40589991 · DOI 10.3389/fneur.2025.1592690

Verify or expand the search:

Other recruiting trials for Sleep-Disordered Breathing

Currently open trials in the same condition.

NCT07147803 — Sleep Quality in Patients With Non-cystic Fibrosis Bronchiectasis · active not recruiting
NCT06576830 — Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia · Phase 4 · recruiting
NCT06255613 — Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor · NA · active not recruiting
NCT06498544 — HighCycle Study: Effect of High Altitude on Sleep Disordered Breathing in Women Related to Their Menstrual Cycle Phase · recruiting
NCT06498531 — HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men · Phase 4 · recruiting

Other Huxley Medical, Inc. trials

Trials by the same sponsor.

NCT06513637 — 12 Lead ECG Database · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06070389 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Huxley Medical, Inc.
Last refreshed: 14 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06070389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing